LABO DéESSE
The computed 12-month bankruptcy probability of LABO DéESSE is 0.9% (low). The 2025 annual accounts show negative equity (€-100k) and a net result of €-110k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 25% of 35 sector peers (fiscal year 2025). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-100k |
| Net result | €-110k |
| Better than sector | 25% |
| Active | 5 yrs |
Strong profile, led by profitability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -12.5% | 45.1% | |
| Net result | €-110k | €2k | |
| Equity | €-100k | €206k | |
| Total assets | €799k | €1.47M |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €-49k |
| Net profit | €-110k |
| Cash flow | €-62k |
| Staff costs | €37k |
| Income taxes | €55 |
| Dividends | - |
| Total assets | €799k |
| Equity | €-100k |
| Debt | €899k |
| of which ≤ 1y | €344k |
| of which > 1y | €555k |
| Working capital | €321k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 1.93 |
| Quick ratio | 1.75 |
| Working capital ratio | 40.2% |
| Solvency | -12.5% |
| Debt / equity | -8.98 |
| Long-term debt ratio | -5.54 |
| Interest coverage | -2.80 |
| Gross margin | - |
| Net margin | - |
| ROA | -13.8% |
| ROE | 110.3% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €799k |
| Fixed assets | 21/28 | €125k |
| Formation expenses | 20 | €10k |
| Intangible fixed assets | 21 | €122k |
| Tangible fixed assets | 22/27 | €2k |
| Current assets | 29/58 | €665k |
| Stocks & contracts in progress | 3 | €63k |
| Amounts receivable within one year | 40/41 | €98k |
| Cash & bank | 54/58 | €479k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €799k |
| Equity | 10/15 | €-100k |
| Contributions / capital | 10/11 | €405k |
| Accumulated profits (losses) | 14 | €-505k |
| Amounts payable | 17/49 | €899k |
| Amounts payable after one year | 17 | €555k |
| Amounts payable within one year | 42/48 | €344k |
| Trade debts payable within one year | 44 | €256k |
| Income statement | ||
| Gross operating margin | 9900 | €-10k |
| Operating result | 9901 | €-97k |
| Financial income | 75 | €4k |
| Financial charges | 65 | €17k |
| Result before taxes | 9903 | €-110k |
| Income taxes | 67/77 | €55 |
| Net result for the period | 9904 | €-110k |
| Result to be appropriated | 9905 | €-110k |
| NACE primary | 20420 |
| Legal form | Private limited company(610) |
| Incorporation | 08-10-2020 |
| Status | Active |
| Postal code | 9120 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 46502D0467/00B002 | Flanders | 125 m² | 1 · 108 m² | 12.1 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
21-01-2025 2 directors appointed
- Mira De Maeyer, Bestuurder
- Adriaan de Leeuw, Vaste vertegenwoordiger
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Mira De Maeyer",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": "niet_statutair",
"compensated": null,
"effective_date": "2024-10-23",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2026"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Adriaan de Leeuw",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": "0474.966.438",
"name": "Ad-Ministerie BV",
"address": "Brusselsesteenweg 66, 1860 Meise",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-01-21",
"filing_date": "2025-01-10",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2024-10-23",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0755.856.068",
"name_full": "LABO D\u00E9ESSE",
"legal_form": "BV",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0474.966.438",
"org_name": "Ad-Ministerie BV",
"person_name": null,
"org_rep_person_name": "Adriaan de Leeuw",
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}14-03-2024 Capital increase of €374,937.25
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "share_split",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": 374937.25,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 3131,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 119.75
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 374937.25,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
}
],
"notary": {
"name": "Tom Holvoet",
"firm_city": null,
"firm_name": "Notariaat Holvoet, F\u0026T notarisvennootschap",
"office_city": "Antwerpen",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-03-14",
"filing_date": "2024-03-12",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-03-08",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0755.856.068",
"name_full": "LABO D\u00E9ESSE",
"legal_form": "B.V.",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"Expeditie van de akte",
"Geco\u00F6rdineerde tekst van de statuten met de lijst van de oprichtings en wijzigende akten"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 10000,
"class_name": "Soort A Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 3131,
"class_name": "Soort B Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | LABO DéESSE |